Filing Details
- Accession Number:
- 0001209191-13-036102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-10 16:44:31
- Reporting Period:
- 2013-07-08
- Filing Date:
- 2013-07-10
- Accepted Time:
- 2013-07-10 16:44:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1554979 | E Megan Pace | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139 | Svp, Corp. Communications | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-07-08 | 22,500 | $37.29 | 43,152 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-07-08 | 3,500 | $37.86 | 46,652 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-07-08 | 21,203 | $80.48 | 25,449 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-07-08 | 3,400 | $81.54 | 22,049 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-07-08 | 4,100 | $82.46 | 17,949 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2013-07-08 | 22,500 | $0.00 | 22,500 | $37.29 |
| Common Stock | Stock Option | Disposition | 2013-07-08 | 3,500 | $0.00 | 3,500 | $37.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,500 | 2020-05-09 | No | 4 | M | Direct | |
| 7,750 | 2022-02-01 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $80.48 (range $80.04 to $80.91).
- Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $81.54 (range $81.04 to $81.88).
- Open market sales reported on this line occurred at a weighted average price of $82.46 (range $82.03 to $82.70).
- The option vests in 16 quarterly installments from 05/10/2010.
- The option vests in 16 quarterly installments from 02/02/2012.
Billionaire Hedge Funds
